Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

The purpose of the study is to determine to evaluate safety and tolerability of CPL304110 when administered once daily to adults with advanced solid malignancies.

Trial Details

NCT ID
NCT04149691
Phase
PHASE1
Sponsor
Celon Pharma SA
Status
RECRUITING
Cancer Type
Gastric Cancer
Locations (sample)
  • Gdansk, Poland
  • Nadarzyn, Poland
  • Olsztyn, Poland
  • Otwock, Poland
  • Warsaw, Poland

Key Eligibility Criteria

  • Patient or legal guardian, if permitted by local regulatory authorities, provides informed consent to participate in the study must be performed be…
  • age of ≥25 years old
  • Performance Score ≥70 in accordance with the Karnofsky Performance Score (KPS),
  • life expectancy period of at least 3 months on the screening day,

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →